RET Inhibitor SPP86 Is a Potential Candidate for the Clinical Treatment of Cutaneous Melanoma [Letter]

Drug Design Development and Therapy, Journal Year: 2025, Volume and Issue: Volume 19, P. 1249 - 1250
Published: Feb. 1, 2025
Language: Английский